First Republic Investment Management Inc. lifted its holdings in shares of Boston Scientific Corporation (NYSE:BSX) by 3.6% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 99,055 shares of the medical equipment provider’s stock after acquiring an additional 3,402 shares during the period. First Republic Investment Management Inc.’s holdings in Boston Scientific were worth $2,890,000 at the end of the most recent reporting period.

Other large investors have also bought and sold shares of the company. Swiss National Bank increased its position in shares of Boston Scientific by 2.9% during the second quarter. Swiss National Bank now owns 5,584,930 shares of the medical equipment provider’s stock worth $154,814,000 after acquiring an additional 156,800 shares in the last quarter. Wells Fargo & Company MN increased its position in shares of Boston Scientific by 10.5% during the second quarter. Wells Fargo & Company MN now owns 9,157,768 shares of the medical equipment provider’s stock worth $253,854,000 after acquiring an additional 867,983 shares in the last quarter. Sit Investment Associates Inc. grew its position in Boston Scientific by 37.8% in the 3rd quarter. Sit Investment Associates Inc. now owns 141,710 shares of the medical equipment provider’s stock worth $4,134,000 after purchasing an additional 38,855 shares in the last quarter. Los Angeles Capital Management & Equity Research Inc. grew its position in Boston Scientific by 35,016.2% in the 2nd quarter. Los Angeles Capital Management & Equity Research Inc. now owns 3,042,464 shares of the medical equipment provider’s stock worth $84,337,000 after purchasing an additional 3,033,800 shares in the last quarter. Finally, Greenwood Capital Associates LLC grew its position in Boston Scientific by 71.7% in the 3rd quarter. Greenwood Capital Associates LLC now owns 91,579 shares of the medical equipment provider’s stock worth $2,671,000 after purchasing an additional 38,249 shares in the last quarter. 90.57% of the stock is owned by institutional investors.

In related news, insider Valley Gold Master Fund L. Sun bought 408,006 shares of Boston Scientific stock in a transaction dated Tuesday, November 28th. The stock was purchased at an average cost of $0.45 per share, with a total value of $183,602.70. Also, EVP Timothy A. Pratt sold 11,061 shares of the stock in a transaction that occurred on Monday, October 2nd. The shares were sold at an average price of $29.24, for a total transaction of $323,423.64. Following the transaction, the executive vice president now directly owns 174,681 shares of the company’s stock, valued at $5,107,672.44. The disclosure for this sale can be found here. Insiders have sold a total of 424,698 shares of company stock valued at $12,273,553 over the last three months. Insiders own 0.74% of the company’s stock.

A number of brokerages have issued reports on BSX. Needham & Company LLC raised shares of Boston Scientific from a “buy” rating to a “strong-buy” rating and upped their price objective for the stock from $25.04 to $32.00 in a research report on Friday. Oppenheimer reaffirmed a “hold” rating on shares of Boston Scientific in a research report on Wednesday, November 29th. BMO Capital Markets reaffirmed a “buy” rating and issued a $31.00 price objective on shares of Boston Scientific in a research report on Wednesday, November 29th. TheStreet downgraded shares of Boston Scientific from a “b” rating to a “c+” rating in a research report on Thursday, December 7th. Finally, Zacks Investment Research downgraded shares of Boston Scientific from a “buy” rating to a “hold” rating in a research report on Monday, October 30th. One investment analyst has rated the stock with a sell rating, four have given a hold rating, fourteen have assigned a buy rating and one has given a strong buy rating to the company. The stock currently has an average rating of “Buy” and an average price target of $30.97.

Boston Scientific Corporation (BSX) opened at $25.50 on Tuesday. Boston Scientific Corporation has a 52-week low of $20.81 and a 52-week high of $29.93. The firm has a market cap of $35,387.26, a P/E ratio of 21.12, a PEG ratio of 1.99 and a beta of 0.96. The company has a debt-to-equity ratio of 0.58, a quick ratio of 0.50 and a current ratio of 0.72.

Boston Scientific (NYSE:BSX) last released its earnings results on Thursday, October 26th. The medical equipment provider reported $0.31 earnings per share for the quarter, meeting the Zacks’ consensus estimate of $0.31. Boston Scientific had a net margin of 9.55% and a return on equity of 23.60%. The firm had revenue of $2.22 billion during the quarter, compared to the consensus estimate of $2.21 billion. During the same period in the prior year, the firm earned $0.27 EPS. The company’s revenue was up 5.6% compared to the same quarter last year. sell-side analysts anticipate that Boston Scientific Corporation will post 1.25 earnings per share for the current fiscal year.

TRADEMARK VIOLATION WARNING: “First Republic Investment Management Inc. Acquires 3,402 Shares of Boston Scientific Corporation (BSX)” was originally published by Watch List News and is the property of of Watch List News. If you are reading this piece of content on another publication, it was illegally copied and republished in violation of US and international copyright and trademark law. The legal version of this piece of content can be viewed at https://www.watchlistnews.com/first-republic-investment-management-inc-acquires-3402-shares-of-boston-scientific-corporation-bsx/1759064.html.

Boston Scientific Profile

Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company offers its products by seven businesses: Interventional Cardiology, Cardiac Rhythm Management, Endoscopy, Peripheral Interventions, Urology and Pelvic Health, Neuromodulation, and Electrophysiology.

Institutional Ownership by Quarter for Boston Scientific (NYSE:BSX)

Receive News & Ratings for Boston Scientific Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Boston Scientific Corporation and related companies with MarketBeat.com's FREE daily email newsletter.